Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07485582 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Exploration of Current and New Technologies for Accuracy of Diagnosing OSA

StatusNot Yet Recruiting
PhaseNot specified
SponsorResMed
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Apr 2026 to Sep 2026
    • Study sites: 7 to 5
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
ResMed
18 trials monitored
See 2 trials at risk
Resmed is the manufacturer of medical devices which screen, diagnose, treat and monitor people with sleeping and respiratory disorders, such as obstructive sleep apnea (OSA). From time to time, for regulatory, quality, and marketing purposes, there may be a need to test the various products performance against PSG (gold standard technology), and other products. The purpose of this study is: 1. Products performance against PSG 2. comparison against other products, and 3. Assessments of potential new technologies
Trial Details
NCT Number NCT07485582
Lead Sponsor ResMed
Collaborators: KlinEra Global Services
Conditions
(from sponsor)		 Obstructive Sleep Apnea
Related terms Sleep Apnea, Obstructive
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov